Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study

Objectives: We aimed to evaluate the drug retention rate and safety of secukinumab (SEC) in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) in a real clinical setting.Methods: This multicenter retrospective observational study included all AxSpA and PsA patients who recei...

Full description

Bibliographic Details
Main Authors: Sara Alonso, Ignacio Villa, Sabela Fernández, José L. Martín, Lilyan Charca, Marina Pino, Leyre Riancho, Isla Morante, Monserrat Santos, Anahy Brandy, Elena Aurrecoechea, Loreto Carmona, Rubén Queiro
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Medicine
Subjects:
secukinumab
safety
survival
spondyloarthritis
psoriatic arthritis
comorbidities
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.679009/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.679009/full

Similar Items